Free Trial

Evelo Biosciences (EVLO) Insider Trading & Ownership

Evelo Biosciences logo
$0.0005 0.00 (0.00%)
(As of 12/20/2024 ET)

Evelo Biosciences (NASDAQ:EVLO) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.02%
Number Of
Insiders Buying
(Last 3 Years)
1
Amount Of
Insider Buying
(Last 3 Years)
$52.50 M
Number Of
Insiders Selling
(Last 3 Years)
5
Amount Of
Insider Selling
(Last 3 Years)
$79,065.76
Get EVLO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Evelo Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

EVLO Insider Buying and Selling by Quarter

Evelo Biosciences Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/8/2023Marella ThorellCFOSell1,811$0.33$597.63  
11/8/2023Mark BodmerInsiderSell3,163$0.33$1,043.79  
11/8/2023Simba GillCEOSell172$0.33$56.76  
9/28/2023Simba GillCEOSell1,996$3.94$7,864.24  
8/8/2023Marella ThorellCFOSell2,004$9.51$19,058.04  
8/8/2023Mark BodmerInsiderSell3,128$9.51$29,747.28  
8/8/2023Simba GillCEOSell342$9.51$3,252.42  
7/11/2023Ventures Fund Iv Gene FlagshipMajor ShareholderBuy5,411,255$2.31$12,499,999.05  
5/23/2023Mark BodmerInsiderSell1,128$2.80$3,158.40  
5/8/2023Duncan MchaleInsiderSell3,336$2.60$8,673.60  
5/8/2023Marella ThorellCFOSell1,926$2.60$5,007.60  
5/8/2023Simba GillCEOSell176$2.60$457.60  
1/23/2023Stephen J CarriereInsiderSell7$21.20$148.40  
5/27/2022Ventures Fund Iv Gene FlagshipMajor ShareholderBuy1,369,862$29.20$39,999,970.40  
(Data available from 1/1/2013 forward)

EVLO Insider Trading Activity - Frequently Asked Questions

The list of insiders at Evelo Biosciences includes Duncan Mchale, Marella Thorell, Mark Bodmer, Simba Gill, Stephen J Carriere, and Ventures Fund Iv Gene Flagship. Learn more on insiders at EVLO.

1.02% of Evelo Biosciences stock is owned by insiders. Learn more on EVLO's insider holdings.

The following insider purchased EVLO shares in the last 24 months: Ventures Fund Iv Gene Flagship ($12,499,999.05).

Insiders have purchased a total of 5,411,255 EVLO shares in the last 24 months for a total of $12,499,999.05 bought.

The following insiders have sold EVLO shares in the last 24 months: Duncan Mchale ($8,673.60), Marella Thorell ($24,663.27), Mark Bodmer ($33,949.47), Simba Gill ($11,631.02), and Stephen J Carriere ($148.40).

Insiders have sold a total of 19,189 Evelo Biosciences shares in the last 24 months for a total of $79,065.76 sold.

Evelo Biosciences Key Executives

  • Mr. Craig R. Jalbert CIRA (Age 62)
    President, Secretary, Principal Executive, Financial and Accounting Officer & Director
  • Dr. Chun Zhang Ph.D.
    Chief Technical Operations & Quality Officer
  • Dr. Mark Bodmer Ph.D. (Age 66)
    Chief Scientific Officer and President of Research & Development
    Compensation: $668.8k
  • Ms. Jessica Cotrone
    VP & Head of Communications
  • Ms. Leslie Wardwell-Scott Ph.D.
    VP and Head of Corporate Development & Strategic Integration
  • Dr. Andrea Itano Ph.D.
    Head of Research
  • Dr. Duncan McHale M.D. (Age 57)
    MBBS, Ph.D., Chief Medical Officer
    Compensation: $661.97k
  • Mr. Douglas Maslin
    Senior Director & Immunology Clinical Lead


This page (NASDAQ:EVLO) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners